Organon & Co.
OGN
$7.17
-$0.19-2.58%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 501.00M | 700.00M | 750.00M | 864.00M | 1.30B |
| Total Depreciation and Amortization | 342.00M | 319.00M | 296.00M | 277.00M | 260.00M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 207.00M | 48.00M | 72.00M | 76.00M | -450.00M |
| Change in Net Operating Assets | -101.00M | -241.00M | -180.00M | -278.00M | -165.00M |
| Cash from Operations | 949.00M | 826.00M | 938.00M | 939.00M | 946.00M |
| Capital Expenditure | -172.00M | -168.00M | -161.00M | -175.00M | -199.00M |
| Sale of Property, Plant, and Equipment | 3.00M | 4.00M | 4.00M | 4.00M | 2.00M |
| Cash Acquisitions | -241.00M | -241.00M | -241.00M | -166.00M | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -211.00M | -176.00M | -191.00M | -176.00M | -101.00M |
| Cash from Investing | -621.00M | -581.00M | -589.00M | -513.00M | -298.00M |
| Total Debt Issued | 880.00M | 580.00M | 1.28B | 1.19B | 1.04B |
| Total Debt Repaid | -1.16B | -788.00M | -1.29B | -1.20B | -1.05B |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -18.00M | -19.00M | -21.00M | -22.00M | -20.00M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -158.00M | -229.00M | -298.00M | -297.00M | -296.00M |
| Other Financing Activities | -2.00M | -2.00M | -38.00M | -38.00M | -36.00M |
| Cash from Financing | -456.00M | -458.00M | -369.00M | -368.00M | -363.00M |
| Foreign Exchange rate Adjustments | 37.00M | 108.00M | -8.00M | -76.00M | 64.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -91.00M | -105.00M | -28.00M | -18.00M | 349.00M |